The Hunger We Don’t See

What if medicine were still operating at the level of the textbook diagram?

What if the schematics taught in medical schools were misleading everyone into believing that a cell is a cell is a cell — let’s draw it as a circle for simplicity’s sake — only to be told, on page 1457, tucked into a single paragraph, that cells in nearly all modern humans actually lack the most basic cation that holds them together: potassium? What if doctors were learning countless mechanisms, chiefly to pass their exams, without ever realising that most of those mechanisms do not work in people the way they do in textbooks?

What if hunger — this crime against humanity, striking far more people than two hijacked planes or an entire carpet-bombing campaign ever have — were not only unfolding by the millions in post-colonial countries and among the ever-growing class of the working poor, but also within our modern societies, where anyone walking into a doctor’s office with a complaint walks out with a “normal test” and one or two of the usual drugs (antidepressants, neurostimulants, cholesterol-lowering, blood-pressure-lowering, anti-inflammatory, …), understanding less and asking fewer questions than when they came in — because this medical world runs on the same textbook-diagram simplifications? The nutrients that would make sense of the complaint — vitamins, conditionally essential compounds (choline, creatine, taurine, and others), minerals, essential and semi-essential fatty acids — are simply not tested, or worse, tested in a manner that ensures the result will nearly always come back “normal.”

The hunger we see around us is ourselves, as well.

A survey of what medicine doesn’t see

The clinical world speaks in the language of “results.” A test was ordered, a value came back, a decision followed. The trust invested in this chain — patient in doctor, doctor in laboratory, laboratory in reference range — depends on assumptions that are almost never spelled out. What follows is a taxonomy of the ways this chain breaks: not always dramatically, more often silently. Every category costs lives.

1. Tests never ordered — the silent floor

The largest failure mode leaves no trace in the medical record. It generates no false result to argue about. It simply does not happen.

Consider what is almost never in a standard blood panel:

• Red-blood-cell magnesium, the marker that reflects intracellular status. Serum magnesium, which is in the panel, reflects less than 1% of total body magnesium (see Magnesium). One of the leading clinical papers on the topic reports that only about 10% of hypomagnesaemia cases are detected by physician request; the remaining 90% are found incidentally. Physicians are not even looking.
• The Omega-3 Index — erythrocyte membrane EPA + DHA as a fraction of total fatty acids. Not part of the standard protocol of any specialty: not cardiology, not neurology, not psychiatry, not rheumatology, not gastroenterology (see Omega-3) — despite decades of evidence linking a low index to sudden cardiac death, cognitive decline, and unresolved chronic inflammation.
• Free T3, reverse T3, thyroid antibodies, salivary cortisol curves, fasting insulin, HOMA-IR, testosterone in women — the tests that would actually characterise the endocrine state of a fatigued, low-mood, low-libido patient (see Optimal Hormonal Levels).
• Erythrocyte glutathione reductase activity coefficient (EGRAC) for riboflavin (see Riboflavin (B2)); erythrocyte transketolase activity coefficient (ETKAC) for thiamine (see Thiamine (B1)). Both are functional markers. Neither is ordered in ordinary practice.
• Gamma-tocopherol, delta-tocopherol, tocotrienols — seven of the eight members of the vitamin E family. Not on any standard panel (see Vitamin E). Only alpha-tocopherol is measured, a structural exclusion of deficiency in the other seven members.
• Methylmalonic acid, holotranscobalamin, plasma homocysteine — the functional markers of a failing methyl cycle. Homocysteine does not appear in standard blood panels (see Folate); it is ordered only on explicit request, usually by a specialist.
• Urinary iodine, 24-hour urinary potassium — the standard field markers of dietary adequacy for two of the most consequential minerals in twentieth-century public health nutrition. Not on any routine panel in ambulatory adult medicine.
• Erythrocyte or urinary zinc, plasma selenium, plasma choline and betaine, vitamin K2 status, taurine, creatine status. The entire conditionally essential space, essentially unmeasured in mainstream clinical practice.
• Iodine is not measured by TSH. TSH is a pituitary regulatory signal. A person on the edge of iodine sufficiency can have a perfectly normal TSH and be biochemically hypothyroid at the tissue level. TSH is nevertheless routinely treated as if it settled the iodine question. It does not.

The list could be extended. Each item on it is a decision — usually inherited, rarely deliberate — not to look. The medical system is not blind because it cannot see. It is blind because it has closed the eyes it possesses.

2. Tests done but structurally blind — the homeostatically defended compartment

For a small set of parameters, the body itself has installed the blindness. Serum concentrations of potassium, magnesium, calcium, and sodium are defended within narrow bands by endocrine and renal machinery. The body will draw on cellular and skeletal reserves for months or years to keep the serum value looking normal. The test measures the defended value. It cannot see the depleted reserve.

For potassium, this is the paradigmatic case: 98% of the body’s stock is intracellular at ~150 mmol/L; the ~2% that circulates extracellularly is defended within 3.5–5.0 mmol/L, and it is that fraction alone that the routine test reports (see Potassium).

For magnesium, the same structural failure operates. In the words of the MaGNet network’s clinical review: an individual may be profoundly deficient in total body or intracellular Mg required for various cellular biochemical processes yet have a serum magnesium concentration within normal range (see Magnesium). Roughly 80% of hypertensive patients in one series had documented magnesium depletion despite normal serum values.

The pattern is not a bug in the test. It is the test operating exactly as designed — reporting the compartment it is designed to report — while being used to answer a question about a compartment it cannot see. Using a homeostatically defended marker as a rule-out for tissue depletion is a category error.

3. Tests done but answering the wrong question

A test can measure what it claims to measure and still fail to inform the clinical decision, because the parameter measured stands in only an imperfect proxy relationship to the parameter of interest — a relationship that is stable enough on aggregate to appear valid, and unstable enough on the individual to fail exactly when it matters.

• TSH as a proxy for thyroid adequacy is the most consequential example. TSH is a pituitary signal, not a direct measure of thyroid hormone activity in tissues. Millions of people with the full symptom picture of hypothyroidism — fatigue, weight gain, cold intolerance, depression, cognitive slowing, hair loss — are told their “thyroid is normal” on the basis of a TSH within population ranges (see Optimal Hormonal Levels). Free T3, the hormone biologically active at the tissue level, may be low while TSH remains obedient.
• EGRAC for riboflavin is unusable in G6PD deficiency — a condition common in African, Mediterranean, and Asian populations — and returns falsely normal results. In riboflavin transporter deficiency (RTD), cells can be starved of B2 with a normal EGRAC because the defect lies downstream of the transport step the assay assumes intact (see Riboflavin (B2)).
• Alpha-tocopherol as a marker for the vitamin E family measures one member of an eight-molecule family with functionally distinct roles. The catastrophic SELECT trial dosed synthetic dl-alpha-tocopherol at pharmacological levels, actively depleted gamma-tocopherol (plasma values fell to 30–50% of baseline in supplemented subjects), and concluded that “vitamin E increases prostate cancer risk” (see Vitamin E). The molecule measured was not the molecule that mattered.
• CRP or IL-6 as markers of inflammation describe the inflammatory state, not the resolving capacity — which depends on omega-3-derived resolvins, protectins, and maresins, none of which are measured in standard panels (see Omega-3). A “normal” CRP does not mean the resolution machinery is intact.
• Serum folate as a proxy for methyl-cycle function. A single meal rich in green vegetables can normalise serum folate for days. Erythrocyte folate reflects average status over 2–3 months, and roughly 5% of people with a normal serum folate are deficient on the erythrocyte test (see Folate). Yet erythrocyte folate is ordered rarely; the SAM/SAH ratio and methyl flux never.

4. Tests done but masked by confounders

Some tests are undermined not by their own physiology but by co-existing conditions that distort the reading in the very patients most likely to be deficient.

• Ferritin masked by inflammation. Ferritin is an acute-phase reactant: it rises with almost any inflammatory process, obscuring iron deficiency in chronic infection, autoimmune disease, obesity, or hepatic disease. A patient with true iron depletion and low-grade inflammation can carry a ferritin “well within range” while tissue iron collapses.
• 25-OH-vitamin D distorted by adipose sequestration. In obesity, a substantial fraction of circulating 25-OH-D is sequestered in adipose tissue and unavailable to the receptor. The serum value can appear reasonable while functional status is deficient.
• Serum vitamin E raw versus lipid-corrected. Vitamin E travels on plasma lipoproteins. A raw serum alpha-tocopherol without correction for total cholesterol and triglycerides misclassifies more than one patient in two: 47% of “low” results prove normal after correction, and 58% of “high” results prove low or normal (see Vitamin E). The lipid-corrected ratio is rarely calculated in routine practice.
• Unmetabolised folic acid (UMFA) masking B12 deficiency. Excess synthetic folic acid — the standard supplement, the standard fortificant — corrects the megaloblastic anaemia that historically signalled B12 deficiency, while the neurological damage of that deficiency continues to progress. In patients with low B12, elevated serum folate is associated with a paradoxical worsening of both homocysteine and methylmalonic acid (see Folate). The historically decisive marker used to declare victory on the anaemia disguises continuing damage.
• Plasma riboflavin normalised by a single dairy meal. Plasma B2 reflects only 48–72 hours of intake, and a meal rich in dairy shortly before the blood draw can artificially normalise the result (see Riboflavin (B2)).

The system rarely names its own confounders, and rarely instructs the ordering physician to reject the result in their presence.

5. Tests done but interpreted against reference ranges built from deficient populations

A test is ordered. The result is reported. A “reference range” appears alongside it. The physician reads the result against that range and concludes normalcy — without asking where the range came from.

Reference ranges are typically constructed by sampling a “healthy” population and taking the central 95% of values. If the population itself is chronically deficient, the range is a description of the deficient state, not of physiological adequacy.

• Magnesium. The MaGNet international network has argued that current serum thresholds (0.70–0.75 mmol/L) are too low, and that the true lower bound of adequacy is closer to 0.85 mmol/L (see Magnesium). Laboratories have not adopted the revision.
• Folate. Roughly 20% of the US population remains insufficient by NHANES analyses even after two decades of mandatory fortification, and elderly participants in the “low-normal” quartile of serum folate carry a 1.3-fold higher risk of cognitive impairment (see Folate). The “normal” range is not adequate.
• Optimal Hormonal Levels. Reference ranges in hormonal medicine are derived from population distributions, not from functional physiological targets: what is statistically “normal” for a population may be biologically inadequate for a given individual (see Optimal Hormonal Levels).
• Riboflavin. The NIH considers deficiency “rare,” yet a Canadian survey found 40% biochemical deficiency among young women with theoretically adequate dietary intake (see Riboflavin (B2)).
• Vitamin E. Over 90% of Americans do not reach the RDA — but the clinical deficiency threshold (< 5 mcg/mL) is set so low that authorities can call deficiency “rare” without contradiction (see Vitamin E).

The reference range is not a fact about the body. It is a fact about the population from which it was sampled. When that population is itself compromised, the range does not measure adequacy — it measures the average shape of the deficit. The patient told they are “normal” learns, in that moment, only that they resemble their equally depleted neighbours.

Why the failures survive

None of these failure modes is a technical mystery. Every one has been described in the peer-reviewed literature for years, and in most cases for decades. They persist not because they are unknown but because the institutional system around them has organised itself to make correction costly and inaction free.

Reimbursement. The tests that would actually inform — RBC-magnesium, Omega-3 Index, MMA, holotranscobalamin, urinary iodine, functional cortisol curves — are rarely covered. The tests that fail are covered. Following the standard of care means following the reimbursement code.

Medical education. Cells are drawn as circles. Compartments are collapsed. Serum is treated as if it were the body. The false-negative structure of common tests is not taught because it would undermine the exam grading of the tests it produces. The graduating physician has internalised the reassurance function of the panel long before they have encountered its failure modes.

Evidence-based medicine. The hierarchy of evidence privileges randomised trials with hard endpoints over mechanistic reasoning about tissue compartments. But when the marker used for inclusion, dosing, and outcome measurement is itself blind to the state of interest, the trial cannot generate the evidence that would falsify the marker. The system is closed: EBM cannot correct a failure whose visibility depends on the very tools EBM does not question. (See Rights-based vs evidence-based.)

Legal cover. A “normal” test is a shield. The physician who ordered the standard panel, read the values against the standard range, and prescribed the standard drug is unimpeachable. The physician who ordered an unreimbursed functional test on clinical suspicion, adjusted therapy in the face of a “normal” result, and initiated a therapeutic trial is exposed. The incentive structure rewards ignorance and penalises attention.

Denial of the aggregate. When 4 billion people are folate-insufficient, 90% of hypomagnesaemia is missed, 20% of the US population remains folate-inadequate two decades after fortification, and 90% of Americans do not reach the vitamin E RDA — the scale of the failure exceeds what the institutional imagination can register as a crisis. It becomes background. It becomes “what people have.” It becomes normal in the statistical sense that eats the physiological sense alive.

What the rights framework demands

The physiological rights framework does not ask for a better test alone. It asks for the abandonment of a specific epistemic posture: that a lab value returned within a reference range, in a patient with clinical symptoms, constitutes a rule-out for the corresponding physiological state.

Concretely:

1. Composite clinical assessment as the primary evidentiary unit. Symptoms, dietary intake, ongoing losses (sweat, gastrointestinal, renal, medication-driven), co-nutrient status, and family and environmental history — read together, not filtered through a single lab result.
2. Functional and alternative markers reimbursed. RBC-magnesium, Omega-3 Index, MMA, homocysteine, urinary iodine, 24-hour urinary potassium, full thyroid panel including fT3 and reverse T3, salivary cortisol curves, fasting insulin and HOMA-IR — moved from specialist-only to standard.
3. Therapeutic trial as evidence. A symptomatic patient with a plausible deficit, given an adequate trial of the missing nutrient, whose symptoms resolve, is a diagnostic event. The current framework treats this as anecdote. A rights framework treats it as what the test could not do.
4. Reference ranges rewritten against functional endpoints, not population averages. Adequacy is what supports full function, not what resembles the median compatriot.
5. The end of the test-as-rule-out where its physiology forbids it. Serum K cannot rule out tissue K depletion. Serum Mg cannot rule out intracellular Mg depletion. TSH alone cannot rule out functional hypothyroidism. Ferritin cannot rule out iron deficiency in the presence of inflammation. These are not opinions. They are structural facts. A rights-based clinical protocol names them explicitly.
6. The named right. Every person has the right to have their essential physiological parameters assessed with instruments capable of detecting the state in question, and interpreted against ranges compatible with full function. Denial of this — through refusal to test, through use of an inadequate test, through interpretation against an inadequate range — is a violation of a physiological right.

The hunger among us

The word hunger has been quarantined to a certain geography and a certain economic class. It arrives in the news attached to famines, to war zones, to distant statistics. It is not the word the fatigued forty-year-old office worker in Montréal, Berlin, or Melbourne uses to describe why they cannot get through the afternoon.

But when the cells of that worker are structurally low in potassium, magnesium, active folate, EPA, DHA, gamma-tocopherol, and thiamine — because the environment does not supply them, because the losses have exceeded the intake, because the confounders have piled up, because no one asked and no test would have known — the word hunger is exact. It is not metaphor. It is the same organism running the same shortfalls, generating the same downstream damage, as the anaemic mill worker Lucy Wills identified in Bombay in 1931. The medical world has forgotten how to see this because the tools it points at itself are aimed at the wrong compartments and calibrated against a population already inside the shortfall.

The hunger we see around us is ourselves, as well. And it will remain invisible for exactly as long as we accept that the tests we use to look for it are the ones that cannot find it.